How to architect revenue operations for an orthodontic practice group in 2027

The two architectures competing for an orthodontic group

Every orthodontic practice group building revenue operations in 2027 faces one structural fork that determines almost everything downstream: who carries the contract. Option A is the in-house financed model, where the practice itself extends the payment plan, holds the receivable on its own books, and collects monthly installments over the treatment term. Option B is the third-party financed model, where an outside lender funds the contract at or near case start, pays the practice a discounted lump sum, and assumes the collection relationship with the patient. Most groups end up somewhere on a spectrum between the two, but the architecture of the revenue stack differs sharply depending on where the center of gravity sits.

Under the in-house model, the practice's accounts receivable becomes the single largest asset on the balance sheet. A group starting 100 cases per month at a $6,000 average contract carries roughly $7.2 million in active receivables at steady state across a mix of contracts at various stages of completion. The revenue operations team is effectively running a small consumer lending operation: underwriting decisions at the treatment coordinator's desk, autopay enrollment, missed-payment detection, dunning sequences, hardship renegotiation, and eventual write-off policy. The upside is that the full contracted fee flows to the practice with no discount fee deducted, and the practice controls the patient relationship end to end. The downside is that every point of delinquency is a direct hit to realized production, and the operational burden of collections scales linearly with case volume.

Under the third-party model, the lender pays out shortly after the case starts, minus a merchant discount fee. Cash conversion is nearly immediate, receivable risk transfers off the practice's books, and the revenue operations team stops running collections entirely for those contracts. What the practice gives up is the discount fee on every funded contract, plus the reality that some share of patients will not qualify for third-party approval at the contract value the treatment plan requires. Approval rates vary by patient credit profile and by the size of the amount financed, which means the practice cannot simply declare "we only use third-party financing" and expect the consult conversion rate to hold — a portion of otherwise-startable cases will fail underwriting and walk if there is no fallback.

There is a third structural variable that cuts across both: the down payment. A larger down payment collected at contract signing shrinks the financed balance, improves third-party approval odds, reduces in-house delinquency exposure, and front-loads cash. It also raises the barrier at the exact moment of conversion, which is where a group can quietly trade case starts for cash-flow comfort without anyone noticing the tradeoff in the reporting.

The architectural question is therefore not "which financing model is better" in the abstract. It is: what mix of in-house versus third-party, at what down-payment level, produces the highest collected production per case start after fees, delinquency, and lost conversions — and what data infrastructure lets you actually measure that rather than guess at it?

How to decide between in-house and third-party financing

The decision should be made per case at the point of contract, not once at the group level, and it should be made by a rule the system enforces rather than by treatment-coordinator improvisation. The inputs are patient credit profile, contract value, insurance coverage amount, and the down payment the patient can put down at signing. The output is a financing waterfall: the sequence of offers the coordinator presents, in order, until one is accepted.

A workable waterfall for most groups looks like this. First, verify orthodontic insurance benefits and subtract the covered portion — orthodontic coverage is typically a lifetime maximum rather than an annual one, so it pays out over the treatment term rather than resetting. Second, collect a down payment against the patient-responsible remainder. Third, run the residual balance through third-party approval. Fourth, if the lender declines or approves only a partial amount, fall back to an in-house plan for the declined portion rather than losing the start entirely. This sequence maximizes conversion while pushing as much receivable risk off the books as underwriting allows.

The group-level decision that remains is the *policy* underneath the waterfall: minimum down payment, maximum in-house term length, and whether to attempt in-house at all for patients with weak credit profiles. Set the minimum down payment too high and consult conversion drops; set it too low and in-house delinquency rises. Set the maximum in-house term too long and receivables balloon past the treatment term, meaning you are still collecting on patients who finished treatment and no longer have a clinical reason to visit — historically the hardest dollars in the practice to collect.

The critical design point is the loop back to the down-payment step on a lender decline. A coordinator who hears "declined" and immediately drops to a long in-house term has skipped the cheapest available fix — raising the down payment by a few hundred dollars often moves a borderline residual under the approval threshold. That behavior only happens reliably if the system prompts it.

The second design point is that every branch of this flowchart must be tagged in the record, so that months later the reporting can answer: what is the collection completion rate on in-house contracts versus third-party, at each down-payment band, by coordinator, by location? Without the tag, the financing mix is unmeasurable and the policy can never be tuned with evidence.

The concrete numbers behind each path

Start with the units of the business. A single case is a multi-month treatment contract — comprehensive treatment commonly runs somewhere in the 18-to-30-month range, with shorter courses for limited or early (Phase I) treatment. The contract is typically structured as a down payment plus monthly installments spread across roughly the treatment term. That structure means the practice's cash from a case start arrives over years, not weeks, and revenue for accounting purposes is recognized as treatment progresses rather than at signing.

Now the arithmetic that makes financing choice matter. Take a group starting 100 cases per month at a $6,000 average contract — $600,000 in newly contracted production monthly, $7.2 million annually. Model it three ways:

Fully in-house. The practice collects the entire $6,000 per case, but carries the full receivable. At a 5% delinquency rate on active contracts, roughly $360,000 of that annual $7.2 million is at risk in any given year, and some fraction of it becomes a write-off after collection costs. The team needs staffed collections capacity: someone owns the aging report, works missed payments daily, and manages hardship modifications. Realized production lands below gross contracted production by whatever the ultimate uncollected share turns out to be, plus the labor cost of chasing it.

Fully third-party. The practice receives the funded amount minus the lender's discount fee shortly after start. Cash conversion is fast and collections labor drops near zero for funded contracts. But if some meaningful share of patients cannot qualify at the residual amount you are asking them to finance, and you have no fallback, those cases do not start. A group that loses even 10 of 100 monthly starts to failed underwriting has given up $60,000 in monthly contracted production — $720,000 annually — to save a discount fee on the 90 that did fund. On those numbers, conversion loss dominates fee savings almost every time.

Hybrid with a waterfall. Most of the volume funds through third-party, and the in-house plan exists specifically to catch declines and partial approvals rather than as the default. This keeps the receivable book small enough to manage with modest collections staffing while protecting the conversion rate that actually drives production.

The reason hybrid usually wins is the relative magnitude of the two leaks. Consult conversion is the larger lever by a wide margin: each unconverted new-patient exam forfeits an entire contract, while each point of delinquency forfeits only the uncollected tail of one. If a location runs 50 new-patient exams a week and converts 20, lifting conversion by five percentage points adds roughly two and a half starts weekly — on a $6,000 average contract, that is about $15,000 in weekly contracted production, or $780,000 annualized, from a change in process rather than a change in marketing spend.

That is why the north-star metric should be collected production per case start, not gross production and not case starts alone. Collected production per case start is total collections divided by total case starts over a matched period, and it moves when either conversion quality or collection completeness moves. A location that starts many low-fee, heavily discounted cases with weak down payments can post impressive start counts and disappointing collected production per start — the metric catches that; a start counter does not.

Two supporting numbers belong on the same dashboard. Contract collection rate — actual collections divided by scheduled payments on active contracts in the period — isolates collection discipline from conversion. And A/R aging by bucket on in-house contracts, watched at the 30/60/90-day lines, is the early-warning system; delinquency that shows up at 90 days was almost always visible at 30 and simply not worked.

Implementation details and sequencing

Build this in a deliberate order, because sequencing errors are expensive. The most common failure is buying an analytics layer before the underlying records are clean enough to analyze, which produces dashboards nobody trusts and a quiet return to the old spreadsheets.

Phase one: establish the source of truth. The orthodontic PMS — Dolphin Management, Cloud 9 Ortho, and tops Ortho are the well-known platforms in this category — holds patients, exams, treatment plans, contracts, and ledgers. Nothing else may hold a competing version of any of those records. Before any integration work begins, audit the existing data: are exams consistently recorded as exams, are treatment plans attached to the exam that produced them, is contract value stored as a structured field rather than living in a note, is the lead source captured at scheduling rather than reconstructed later? Fixing these is unglamorous and takes weeks, and every downstream metric depends on it.

Phase two: instrument the consult. Every new-patient exam needs a structured outcome: started, pending, or declined — and if not started, a reason code from a fixed short list (cost, insurance limitation, scheduling conflict, chose another provider, deferred for growth). Free-text reasons are unanalyzable. Add two timestamps: exam date to plan-presentation date, and plan-presentation date to case start. Same-day presentation should be the standard; when it slips, you want the data to show where.

Phase three: automate the financing waterfall. Encode the decision tree from the flowchart above into the consult workflow so the coordinator is prompted through it rather than remembering it. Capture the financing path taken on every contract. Require autopay enrollment on in-house plans as a condition of the plan — a plan billed by paper statement is a plan you will chase.

Phase four: build the collection compliance loop. Reconcile scheduled payments against actual collections continuously rather than at month-end. A missed payment should generate an alert within about 24 hours of the scheduled date, not 30 days later. Build an escalation sequence that moves from automated text and email reminder with an embedded payment link, to a second reminder, to human outreach within roughly a week. Track modifications — rescheduled payments, extended terms, partial payments — as structured events that recalculate the contract's expected completion date, so the aging report reflects reality rather than the original schedule.

Phase five: connect the systems. Marketing platform to PMS, so every exam is attributable to its originating source. PMS to billing and claims, so treatment plan fees and contract schedules flow without double entry. Billing to accounting — QuickBooks or a mid-market ERP such as Sage Intacct for larger groups — so deposits post with enough detail to attribute collections back to provider and location. Each connection should be one-directional with a clear owner; bidirectional syncs between systems that both allow edits are the fastest route to irreconcilable ledgers.

Phase six: standardize across locations. A multi-location group's biggest hidden variance is that each office runs its own consult script, its own down-payment discretion, and its own collections diligence. Publish the policy, enforce the minimums in the system, and then report conversion and collection rate by location so outliers are visible. Gaidge is a widely used analytics layer that sits on top of orthodontic PMS data for exactly this kind of group-level comparison.

The weekly operating review is the piece most groups skip, and it is what makes the rest of the architecture worth building. Compare actual starts to expected starts from the exam pipeline, read the reason codes on non-starts, look at the 30-day A/R bucket before it becomes the 90-day bucket, and check whether any location's conversion or collection rate has drifted from the group. The loop back into the review in the diagram is intentional — this is a standing cadence, not a one-time build.

Where the architecture typically breaks

Three failure patterns recur often enough to design against explicitly.

The retention gap. Treatment ends, the patient moves to retainers, and the practice still holds an in-house balance. Clinical leverage is gone, appointment frequency drops, and collection difficulty rises sharply. The structural fix is to set in-house terms so the final payment lands at or before debonding — if the contract term exceeds the estimated treatment term, you have designed the problem in.

Insurance treated as an afterthought. Orthodontic benefits typically pay against a lifetime maximum and often disburse over the treatment period rather than in a single payment. If benefits are not verified before the contract is papered, the patient-responsible amount is wrong from day one, and every downstream number — down payment, financed residual, monthly installment — inherits the error. Verify before presenting, not after starting.

Attribution that stops at the lead. Many groups track cost per lead and cost per new-patient exam but never connect spend to *started, collected* cases. A channel producing cheap exams that convert poorly is more expensive than a channel producing costly exams that convert well, and only start-level and collection-level attribution reveals it. The marketing-to-PMS integration in phase five exists specifically so this question is answerable.

A fourth, subtler pattern: treating an orthodontic group like a general dental practice. General dentistry is largely per-visit fee-for-service with revenue realized close to the point of care. An orthodontic practice group is a case-based, contract-financed, long-treatment business. Chair-time production metrics imported from general dentistry will point the group at the wrong levers — utilization matters, but it is a capacity constraint, not the revenue driver. The revenue driver is starting cases and collecting contracts.

Related questions

Should a small two-location group build this or stay on spreadsheets?

Build phases one through four; defer phases five and six. Clean PMS records, structured consult outcomes, an enforced financing waterfall, and a fast missed-payment loop deliver most of the value. Cross-system integration and location benchmarking earn their cost as location count and case volume grow.

How does clear aligner treatment change the economics?

Aligner cases shift cost from chair time to lab expense and often carry different appointment cadence, which changes capacity planning more than it changes the financing architecture. Track contract value and collection rate by treatment type so the mix shift is visible in collected production per start.

What should the treatment coordinator actually own?

Presentation quality, financing-waterfall execution, down-payment collection at signing, and the non-start reason code. They should not own long-tail collections — that is a separate function with different skills and a different cadence, and merging them degrades both.

How long before the reporting is trustworthy?

Expect a full treatment cycle before collection-completion data is meaningful, since contracts started today finish collecting well over a year out. Conversion metrics stabilize far faster — within weeks of clean consult instrumentation.

FAQ

What is the single most important metric for an orthodontic group's revenue operations?

Collected production per case start. It combines the two things that actually drive the business — how well consults convert into contracted cases, and how completely those contracts get collected across the treatment term. Gross production is misleading because it counts contracted dollars that may never arrive, and raw case-start counts are misleading because they ignore fee level and collection risk.

Should we run a separate CRM alongside the orthodontic PMS?

No. The PMS should remain the single source of truth for patients, exams, treatment plans, contracts, and ledgers. A parallel CRM creates two versions of patient state and a permanent reconciliation burden. Integrate marketing and consultation tools *into* the PMS so lead source, exam outcome, and contract data live in one record.

How much of the book should sit on in-house payment plans?

There is no universal number — it depends on your patient population's credit profiles, your down-payment policy, and your collections staffing. The principle is that in-house should function as the fallback that catches lender declines and partial approvals, not as the default path, because every in-house contract adds receivable risk and collections labor.

Why does a missed payment need a 24-hour alert instead of a month-end report?

Because recoverability decays with time. A payment missed yesterday is usually an expired card, a changed bank account, or a temporary cash gap — all fixable with one contact. The same payment surfaced 30 days later has often compounded into two or three missed installments and a harder conversation.

How do we tie marketing spend to revenue rather than to leads?

Capture lead source at scheduling as a structured field in the PMS, carry it through the exam record, and attach it to the resulting contract and its collections. That lets you report cost per case start and, eventually, cost per collected dollar by channel — the only version of marketing ROI that reflects the financed, multi-month nature of orthodontic revenue.

What is the biggest architectural mistake groups make?

Importing a general dental practice's operating model. Orthodontics is case-based and contract-financed with revenue realized over 18 to 30 months, so the levers are consult conversion and collection completeness rather than per-visit production. Groups that measure chair-time production optimize the wrong constraint and leave the actual revenue drivers uninstrumented.

Sources

• https://www.aaoinfo.org/
• https://www.ada.org/
• https://www.dolphinimaging.com/management/
• https://www.cloud9ortho.com/
• https://www.topsortho.com/
• https://www.gaidge.com/
• https://www.orthodonticproductsonline.com/
• https://www.consumerfinance.gov/
• https://www.cms.gov/

Related on PULSE

• [How to architect revenue operations for a multi-location dental group (DSO) in 2027](/knowledge/ra0615)
• [How to architect revenue operations for a multi-location chiropractic clinic group in 2027](/knowledge/ra0640)
• [How to architect revenue operations for an optometry and eye-care practice in 2027](/knowledge/ra0641)
• [How to architect revenue operations for an outpatient physical therapy clinic group in 2027](/knowledge/ra0626)
• [How do you architect revenue operations for a dental practice software company in 2027?](/knowledge/ra0383)